View full meeting coverage »

Eyetube Meeting Coverage:

Retina Updates Spring 2020


Editorially Independent Content, Financially Supported by


Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

OPTIC Study Data

  Channels: Retina | Posted 5/13/2020

Arshad Khanani, MD, MA, shares data from the phase 1 OPTIC trial, which evaluated the intravitreal injection therapy ADVM-022 in patients with wet AMD. Dr. Khanani’s summary includes data about safety, visual function, and anatomic changes from various dosages.

Clinical Trials • Intravitreal Injection • retina-meeting-recap • Wet AMD

4 / 10 Series: Retina Updates Spring 2020

These programs are not affiliated with the official program of ARVO 2020.